The study is registered under NCT05954052 with clincialtrials.gov
Seiwerth, S., Milavi, M., Vukojevi, J., Gojkovic, S., Krezic, I., Vuleti, L., Pavlov, K., Petrovic, A., Sikiri, S., Vrane, H., Prtori, A., Zizek, H., Durasin, T., Dobri, I., Stareini, M., trbe, S., Kneevi, M., ola, M., Kokot, A., Sever, M., Lovri, E., krti, A., Blagaic, A., & Sikiric, P
FGFR1 silencing with the FGFR1-specific tyrosine kinase inhibitor PD166866 increased the sensitivity of MDA-MB-231 cells to IGF-Trap treatment in vivo
Common mouse models of tauopathy reflect early but not late human disease
The X-ray spectroscopy analysis demonstrates the direct and complete binding of the Au atom of auranofin ligand to the Se atom in TXNRD [237]
Our providers are trained to assess your risk and prescribe responsibly